BTMD

Healthcare Medical Care Facilities

biote Corp.

$1.12
-0.03 -2.61% today

Price History

Not enough data

Key Stats

Market Cap
32.12M
Avg Volume
230,523
P/E (TTM)
8.00
EPS
$0.14
52W High
$3.26
52W Low
$1.10
Div. Yield
0.0%

Analyst Ratings

Buy
0
Str Buy
4
Buy
1
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
2.49
P/B Ratio
-0.47
P/S Ratio
0.21
EV/EBITDA
6.20
EV/Revenue
0.86

Margins

Gross Margin 69.4%
Operating Margin 5.3%
Net Margin 3.2%
EBITDA Margin 13.9%

Growth & Returns

Revenue Growth (YoY)
(9.5%)
Return on Assets
13.7%

Liquidity & Leverage

Current Ratio
1.43
Quick Ratio
0.69
Total Cash
11.17M
Total Debt
128.64M

About

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

www.biote.com